- NOVEL HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
-
Provided are heterocyclic compounds of formula (I) as bromodomain and extraterminal (BET) inhibitors, pharmaceutical compositions comprising the compounds, their synthesis and their use for treating diseases and conditions wherein inhibition of one or more BET bromodomains provides a benefit.
- -
-
Page/Page column 53-54; 81-82
(2022/01/24)
-
- Five-membered heterocyclic oxo carboxylic acid compound and medical application thereof
-
The invention relates to a five-membered heterocyclic oxo carboxylic acid compound and a medical application thereof. Specifically, the invention relates to a compound, a pharmaceutical salt, a prodrug, a hydrate, a solvate or a crystal form as shown in a formula (I), and also relates to a preparation method of the compound, a pharmaceutical composition containing the compound and an application of the pharmaceutical composition as a secretion regulator of interferon type I, especially as an STING agonist in preparation of medicines for preventing and/or treating I-type interferon related diseases.
- -
-
Paragraph 1181-1185
(2021/05/01)
-
- FACTOR XIa INHIBITORS
-
The present invention provides a compound of Formula (I); and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.
- -
-
Page/Page column 54
(2016/11/02)
-
- Ring fluorinated thiophenes: Applications to liquid crystal synthesis
-
Ring fluorinated thiophenes were synthesized via a Balz-Schiemann fluorination approach and were successfully employed in the synthesis of liquid crystals using regioselective electrophilic bromination and regioselective Suzuki coupling chemistry.
- Kiryanov, Andre A.,Seed, Alexander J.,Sampson, Paul
-
p. 8797 - 8800
(2007/10/03)
-